Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0032105,
umls-concept:C0035094,
umls-concept:C0138741,
umls-concept:C0205177,
umls-concept:C0205254,
umls-concept:C0205307,
umls-concept:C0348080,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C0681850,
umls-concept:C0752224,
umls-concept:C0871261,
umls-concept:C1550501,
umls-concept:C1704632,
umls-concept:C1706203,
umls-concept:C1706817,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2911692
|
pubmed:issue |
4
|
pubmed:dateCreated |
1982-5-27
|
pubmed:abstractText |
Little is known about changes in inactive plasma renin in various conditions or the in vivo activation mechanism of inactive renin. The effects of various factors known to stimulate or suppress renin release on active and inactive PRA were examined in normal subjects. Inactive PRA was determined as the difference between the total PRA after trypsin activation and active PRA. Concurrent measurements of urinary kallikrein excretion and plasma prekallikrein activity were performed to assess the possible role of renal or plasma kallikrein in in vivo activation of inactive renin. Short term stimulation with iv furosemide and ambulation, infusion of isoproterenol, and administration of captopril increased active PRA, but had little or no effect on inactive PRA. Sodium restriction and sodium loading, each for 4 days, induced parallel changes in active and inactive PRA. The administration of propranolol for 4 days decreased active PRA but did not change inactive PRA. There were no significant correlations between the changes in urinary kallikrein excretion and those in active PRA or in the proportion of active to total PRA after any short term treatments, except furosemide administration. Plasma prekallikrein activity was correlated with the proportion of active renin only during the long term sodium balance study. The present data suggest that the mechanisms ofr the control of inactive and active renin are different. Neither renal nor plasma kallikrein seems to be consistently involved in the in vivo activation of inactive renin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Captopril,
http://linkedlifedata.com/resource/pubmed/chemical/Furosemide,
http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol,
http://linkedlifedata.com/resource/pubmed/chemical/Kallikreins,
http://linkedlifedata.com/resource/pubmed/chemical/Prekallikrein,
http://linkedlifedata.com/resource/pubmed/chemical/Propranolol,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
682-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7037811-Adult,
pubmed-meshheading:7037811-Captopril,
pubmed-meshheading:7037811-Furosemide,
pubmed-meshheading:7037811-Humans,
pubmed-meshheading:7037811-Isoproterenol,
pubmed-meshheading:7037811-Kallikreins,
pubmed-meshheading:7037811-Locomotion,
pubmed-meshheading:7037811-Male,
pubmed-meshheading:7037811-Prekallikrein,
pubmed-meshheading:7037811-Propranolol,
pubmed-meshheading:7037811-Reference Values,
pubmed-meshheading:7037811-Renin,
pubmed-meshheading:7037811-Sodium
|
pubmed:year |
1982
|
pubmed:articleTitle |
Responses of active and inactive plasma renin and changes in urinary kallikrein and plasma prekallikrein to various conditions in normal subjects.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|